Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dienogest effects on macrophage and natural killer cells in adenomyosis
TCTR20150921001Completed
- Sponsor
- Ramathibodi Hospital
- Start
- Oct 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of dienogest in adenomyosis (2 arms), sponsored by Ramathibodi Hospital. Primary endpoint: CD68 expression. Started Oct 2014; status: completed.
02
Drugs
dienogest
03
Conditions
adenomyosis
Beyond the preview
Go deeper on TCTR20150921001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20150921001.